Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure.
Dong-Jin ParkSung-Eun ChoiJi-Hyoun KangKichul ShinYoon-Kyoung SungShin-Seok LeePublished in: Therapeutic advances in musculoskeletal disease (2022)
Our study supported switching to a non-TNF-targeted treatment instead of TNF cycling in patients with RA showing an inadequate response to initial TNFi.